Anaphylaxis: severe episodes in hospital were rare
|
|
The study
Prospective cohort study
with
unblinded, unobjective
outcomes,
not adjusted
for confounding factors,
not
validated in an independent set of patients.
Setting: 9 acute hospitals, Europe and India
123 patients
(aged
median age ~53,
67%
female)
in hospital with severe anaphylaxis
Outcomes studied:
- severe anaphylaxis
- fatal anaphylaxis
- respiratory symptoms
- cardiovascular symptoms
- angioedema or other swelling
- pruritis
The evidence
| outcome |
time to outcome |
number of patients/total number |
%
(95% CI) |
NNF
(95% CI) |
| severe anaphylaxis
|
? |
89/481752 |
0.018%
(0.015% to
0.022%) |
5400 (4500 to
6800)
|
| fatal anaphylaxis
|
? |
2/123 |
1.6%
(0.0% to
3.9%) |
| respiratory symptoms
|
? |
97/123 |
79%
(% to
%) |
| cardiovascular symptoms
|
? |
86/123 |
70%
(62% to
78%) |
| angioedema or other swelling
|
? |
60/123 |
49%
(40% to
58%) |
| pruritis
|
? |
41/123 |
33%
(25% to
42%) |
Comments
- Anaphylaxis may be IgE-mediated (anaphylactic) or triggered by non-IgE mechanisms (anaphylactoid); these subtypes are clinically indistinguishable.
- It is important to note this did not include community cases requiring hospitalisation, moderate or mild reactions of urticaria/angioedema, asthmatics, or intraoperative cases.
Citation
-
The International Collaborative Study of Severe Anaphylaxis
,
:
An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks.
Epidemiology
1998;
9:
141-146
Search Terms:
?
Contributor: Mike Bennett and Chris Ball,
November 1999
Reviewer: David Lang
Clinical Question.
| Patient |
suspected anaphylaxis |
| Intervention or Exposure |
prevalence |
| Outcome |
in-hospital, death |
|
|